Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(8):547; doi:10.1093/jnci/97.8.547
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Randomized Trial of Systematic Lymphadenectomy

Most cases of ovarian cancer are diagnosed at advanced stages, and survival rates are low. A key component of treatment is surgery to remove as much tumor as possible, but whether surgery should include systematic removal of retroperitoneal lymph nodes has been less clear. In this issue, Benedetti Panici et al. (p. 560) report the results of a randomized trial of 427 women with advanced ovarian cancer treated with cytoreductive surgery plus systematic aortic and pelvic lymphadenectomy or with cytoreductive surgery only. After a median follow-up of more than 5.5 years, women in the systematic . . . [Full Text of this Article]

Genetic Polymorphisms and Lung Cancer Risk

HPV and Reactivation in HIV-Positive Women

Immune System Development and Non-Hodgkin Lymphoma

Sex Hormones and Postmenopausal Breast Cancer

Male Breast Cancer Incidence Among Atomic Bomb Survivors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?